NO994233L - Sterol-estere i faste, tabletterte doseringsformer - Google Patents
Sterol-estere i faste, tabletterte doseringsformerInfo
- Publication number
- NO994233L NO994233L NO994233A NO994233A NO994233L NO 994233 L NO994233 L NO 994233L NO 994233 A NO994233 A NO 994233A NO 994233 A NO994233 A NO 994233A NO 994233 L NO994233 L NO 994233L
- Authority
- NO
- Norway
- Prior art keywords
- solid
- dosage forms
- sterol esters
- tableted dosage
- tableted
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
- A61K9/143—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2095—Tabletting processes
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Zoology (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Inorganic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Obesity (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Steroid Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US09/145,528 US6376481B2 (en) | 1998-09-02 | 1998-09-02 | Sterol esters in tableted solid dosage forms |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO994233D0 NO994233D0 (no) | 1999-09-01 |
| NO994233L true NO994233L (no) | 2000-03-03 |
Family
ID=22513518
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO994233A NO994233L (no) | 1998-09-02 | 1999-09-01 | Sterol-estere i faste, tabletterte doseringsformer |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US6376481B2 (no) |
| EP (1) | EP0985411B1 (no) |
| JP (1) | JP2000103737A (no) |
| AT (1) | ATE282405T1 (no) |
| AU (1) | AU764513B2 (no) |
| BR (1) | BR9903992A (no) |
| CA (1) | CA2281251C (no) |
| DE (1) | DE69921919T2 (no) |
| DK (1) | DK0985411T3 (no) |
| NO (1) | NO994233L (no) |
| NZ (1) | NZ337574A (no) |
| PT (1) | PT985411E (no) |
Families Citing this family (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6342249B1 (en) | 1998-12-23 | 2002-01-29 | Alza Corporation | Controlled release liquid active agent formulation dosage forms |
| EP1140027B1 (en) * | 1998-12-23 | 2005-10-12 | Alza Corporation | Dosage forms comprising porous particles |
| KR20020026053A (ko) * | 2000-09-30 | 2002-04-06 | 노승권 | 음료용 식물성 스테롤의 분산방법 및 이를 함유하는 음료 |
| JP4547148B2 (ja) * | 2001-06-22 | 2010-09-22 | ベンド・リサーチ・インコーポレーテッド | 非晶質薬剤の吸着物の医薬組成物 |
| WO2003063833A1 (en) | 2002-02-01 | 2003-08-07 | Pfizer Products Inc. | Pharmaceutical compositions of amorphous dispersions of drugs and lipophilic microphase-forming materials |
| US7994153B2 (en) * | 2002-05-20 | 2011-08-09 | Otsuka Pharmaceutical Co., Ltd. | Chloasma amelioration composition and dullness amelioration composition |
| EP1549159B1 (en) | 2002-06-12 | 2008-11-12 | The Coca-Cola Company | Beverages containing plant sterols |
| US7306819B2 (en) | 2002-06-12 | 2007-12-11 | The Coca-Cola Company | Beverages containing plant sterols |
| US6949261B2 (en) | 2002-11-12 | 2005-09-27 | Ayurvedic-Life International, Llc | Compositions for diabetes treatment and prophylaxis |
| US6946151B2 (en) * | 2002-11-12 | 2005-09-20 | Ayurvedic-Life International, Llc | Therapeutic compositions |
| MXPA06001417A (es) | 2003-08-04 | 2006-05-15 | Pfizer Prod Inc | Composiciones farmaceuticas de adsorbatos de farmacos amorfos y materiales que forman microfases lipofilas. |
| BRPI0416747A (pt) * | 2003-11-20 | 2007-01-16 | Zomanex Llc | métodos e formulações para o tratamento de condições médicas relacionadas à dihidrotesterona elevada |
| US8968768B2 (en) * | 2004-03-29 | 2015-03-03 | Wyeth Llc | Phytosterol nutritional supplements |
| CA2560595C (en) * | 2004-03-29 | 2013-01-22 | Wyeth | Multi-vitamin and mineral nutritional supplements |
| DE102005022953A1 (de) * | 2005-05-19 | 2006-11-23 | Chemische Fabrik Budenheim Kg | Nahrungsergänzungsmittel |
| PL2167069T3 (pl) | 2007-05-23 | 2012-04-30 | Amcol International Corp | Krzemiany warstwowe oddziałujące z cholesterolem oraz sposoby zmniejszania hipercholesterolemii u ssaka |
| EP2257173B1 (en) * | 2008-02-27 | 2014-07-30 | Amcol International Corporation | Protonated hydrogen ion-exchanged layered phyllosilicate material for use in treating atherosclerosis |
| US8039025B1 (en) | 2010-10-15 | 2011-10-18 | Life Plus, LLC | Methods and dosage forms for the treatment of human cancers |
| GB201502077D0 (en) * | 2015-02-09 | 2015-03-25 | Cubic Pharmaceuticals Ltd And Delta Pharmaceuticals Ltd | Improved hme technology |
Family Cites Families (39)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB284814A (en) | 1926-11-29 | 1928-02-09 | Leonard Miller | Improvements in or relating to hoists or derricks |
| US3004043A (en) | 1959-10-09 | 1961-10-10 | Eastman Kodak Co | Water-soluble vegetable oil sterol derivatives |
| US3203862A (en) | 1960-03-11 | 1965-08-31 | Jones John Harris | Oral anti-hypercholesterol composition |
| US3495011A (en) | 1968-10-28 | 1970-02-10 | Unimed Inc | Reduction of blood level cholesterol |
| US3865939A (en) | 1973-02-23 | 1975-02-11 | Procter & Gamble | Edible oils having hypocholesterolemic properties |
| US3881005A (en) | 1973-08-13 | 1975-04-29 | Lilly Co Eli | Pharmaceutical dispersible powder of sitosterols and a method for the preparation thereof |
| US4160850A (en) | 1975-08-25 | 1979-07-10 | General Mills, Inc. | Shelf-stable mix for a spreadable butter-substitute |
| US4195084A (en) | 1977-01-07 | 1980-03-25 | Eli Lilly And Company | Taste-stable aqueous pharmaceutical suspension of tall oil sitosterols and a method for the preparation thereof |
| GB1598638A (en) | 1978-04-18 | 1981-09-23 | Gen Mills Inc | Butter-substitute products comprising an emulsifier water oil and hard fat and compositions and processes for the production thereof |
| US4238520A (en) | 1979-06-28 | 1980-12-09 | Scm Corporation | Low-fat comestible spread substitutes |
| US4705875A (en) | 1984-06-13 | 1987-11-10 | Mitchell David C | Substituted fructose compounds and vitamin supplements and methods for making same |
| US4588717A (en) | 1984-06-13 | 1986-05-13 | David C. Mitchell Medical Research Institute | Compounds and vitamin supplements and methods for making same |
| US4883788A (en) | 1986-06-06 | 1989-11-28 | Hauser-Kuhrts, Inc. | Method and composition for reducing serum cholesterol |
| US4824672A (en) | 1986-06-06 | 1989-04-25 | Hauser-Kuhrts, Inc. | Method and composition for reducing serum cholesterol |
| GB8623557D0 (en) * | 1986-10-01 | 1986-11-05 | Boots Co Plc | Therapeutic agents |
| US5082684A (en) | 1990-02-05 | 1992-01-21 | Pfizer Inc. | Low-calorie fat substitute |
| US5306514A (en) | 1990-04-26 | 1994-04-26 | The Procter & Gamble Company | Solid, nondigestible, fat-like compounds and food compositions containing same |
| US5306515A (en) | 1990-04-26 | 1994-04-26 | The Procter & Gamble Company | Reduced calorie pourable shortening, cooking oils, salad oils or like compositions |
| US5514398A (en) | 1990-11-05 | 1996-05-07 | Amano Pharmaceutical Co., Ltd. | Food additive and use thereof |
| AU664827B2 (en) | 1991-05-03 | 1995-12-07 | Raisio Benecol Ltd. | A substance for lowering high cholesterol level in serum and a method for preparing the same |
| US5338563A (en) | 1992-05-01 | 1994-08-16 | Nabisco, Inc. | Process for the preparation of a spatter-resistant low-fat spread |
| GB9220268D0 (en) | 1992-09-25 | 1992-11-11 | Unilever Plc | Cosmetic composition |
| US5326825A (en) | 1992-11-27 | 1994-07-05 | Naesman Jan H | Process for the preparation of a graft copolymer bound catalyst |
| WO1995000158A1 (en) | 1993-06-25 | 1995-01-05 | Bio-Sphere Technology | Dietary supplement incorporating beta-sitosterol and pectin |
| US5472728A (en) | 1994-04-22 | 1995-12-05 | Kraft Foods, Inc. | Edible fat-containing margarine type products and process for preparing same |
| GB9410867D0 (en) * | 1994-05-31 | 1994-07-20 | Ucb Sa | Radiation curable compositions |
| US5770254A (en) | 1994-10-21 | 1998-06-23 | Healthy Foods Solutions, Inc. | Reduced-fat compositions and methods for preparing and using same |
| ES2205701T3 (es) | 1995-06-01 | 2004-05-01 | Unilever N.V. | Productos alimenticios a base de grasas. |
| CA2189202C (en) | 1995-11-02 | 1999-09-28 | Lipidia Holding S.A. | Stable edible oil composition |
| US6139872A (en) | 1996-08-14 | 2000-10-31 | Henkel Corporation | Method of producing a vitamin product |
| US6025010A (en) | 1997-11-21 | 2000-02-15 | Lipton, Division Of Conopco, Inc. | Multifunctional spread |
| IN185730B (no) | 1998-02-19 | 2001-04-14 | Mcneil Ppc Inc | |
| US6110502A (en) * | 1998-02-19 | 2000-08-29 | Mcneil-Ppc, Inc. | Method for producing water dispersible sterol formulations |
| US6025348A (en) | 1998-04-30 | 2000-02-15 | Kao Corporation | Oil and fat composition containing phytosterol |
| SE512958C2 (sv) | 1998-04-30 | 2000-06-12 | Triple Crown Ab | Kolesterolsänkande komposition innehållande beta-sitosterol och/eller beta-sitostanol samt förfarande för dess framställning |
| US6087353A (en) * | 1998-05-15 | 2000-07-11 | Forbes Medi-Tech Inc. | Phytosterol compositions and use thereof in foods, beverages, pharmaceuticals, nutraceuticals and the like |
| US5932562A (en) * | 1998-05-26 | 1999-08-03 | Washington University | Sitostanol formulation to reduce cholesterol absorption and method for preparing and use of same |
| WO1999063841A1 (en) | 1998-06-05 | 1999-12-16 | Forbes Medi-Tech Inc. | Compositions comprising phytosterol and/or phytostanol having enhanced solubility and dispersability |
| US6242001B1 (en) * | 1998-11-30 | 2001-06-05 | Mcneil-Ppc, Inc. | Method for producing dispersible sterol and stanol compounds |
-
1998
- 1998-09-02 US US09/145,528 patent/US6376481B2/en not_active Expired - Lifetime
-
1999
- 1999-09-01 BR BR9903992-3A patent/BR9903992A/pt not_active Application Discontinuation
- 1999-09-01 CA CA002281251A patent/CA2281251C/en not_active Expired - Fee Related
- 1999-09-01 PT PT99306961T patent/PT985411E/pt unknown
- 1999-09-01 AT AT99306961T patent/ATE282405T1/de active
- 1999-09-01 JP JP11247465A patent/JP2000103737A/ja active Pending
- 1999-09-01 EP EP99306961A patent/EP0985411B1/en not_active Expired - Lifetime
- 1999-09-01 NO NO994233A patent/NO994233L/no not_active Application Discontinuation
- 1999-09-01 DE DE69921919T patent/DE69921919T2/de not_active Expired - Lifetime
- 1999-09-01 DK DK99306961T patent/DK0985411T3/da active
- 1999-09-01 AU AU45852/99A patent/AU764513B2/en not_active Ceased
- 1999-09-01 NZ NZ337574A patent/NZ337574A/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| AU4585299A (en) | 2000-03-16 |
| AU764513B2 (en) | 2003-08-21 |
| EP0985411A1 (en) | 2000-03-15 |
| CA2281251A1 (en) | 2000-03-02 |
| DK0985411T3 (da) | 2005-03-14 |
| NZ337574A (en) | 2000-11-24 |
| NO994233D0 (no) | 1999-09-01 |
| PT985411E (pt) | 2005-02-28 |
| CA2281251C (en) | 2008-12-30 |
| JP2000103737A (ja) | 2000-04-11 |
| DE69921919T2 (de) | 2005-11-24 |
| US6376481B2 (en) | 2002-04-23 |
| DE69921919D1 (de) | 2004-12-23 |
| US20010009677A1 (en) | 2001-07-26 |
| ATE282405T1 (de) | 2004-12-15 |
| EP0985411B1 (en) | 2004-11-17 |
| BR9903992A (pt) | 2000-09-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO994233D0 (no) | Sterol-estere i faste, tabletterte doseringsformer | |
| FI973749A7 (fi) | Suun kautta annosteltava 2-metyylitienobentsodiatsepiinivalmiste | |
| DE60027717D1 (de) | Orale zusammensetzung zur pilzbehandlung die itraconazol enthält und herstellungsverfahren davon | |
| DK1075191T4 (da) | Phytosterolsammensætninger | |
| AU3235395A (en) | Integrated process for the manufacture of lactide | |
| ATE385409T1 (de) | Komponenten und verfahren für die verbesserte herstellung von abdrücken | |
| WO2003028576A3 (en) | Method and apparatus for dental implants | |
| TR199600792A2 (tr) | Dihaloazolopirimidinlerin hazirlanmasina yönelik proses. | |
| ATE364620T1 (de) | Amphotere sterole und deren verwendung | |
| IL140419A0 (en) | Novel form of irbesartan, methods for obtaining said form and pharmaceutical compositions containing same | |
| TR199900651T2 (xx) | Kaplanm�� par�ac�k form�lasyonu. | |
| DE59800935D1 (en) | Immuntolerante prothrombinkomplex-präparation | |
| DE60015508T2 (de) | C-16 ungesätigte fp-selektive prostaglandin analoge | |
| ATE193971T1 (de) | Implantat | |
| ES2109103T3 (es) | Procedimiento para la preparacion de trialquilsilil-7 bacatina iii. | |
| DE59902109D1 (de) | Gaskarburierungsverfahren zur Herstellung von reinem WC-Pulver | |
| UA32598C2 (uk) | Спосіб одержання лікарської форми карбамазепіну | |
| FI953480L (fi) | Menetelmä puhtaan maitohapon valmistamiseksi | |
| DE69911224D1 (de) | Geschmacksmaskierte kautablette mit sofortiger wirkstofffreisetzung sowie herstellungsverfahren | |
| PT1246790E (pt) | Bases de mannich de 1- e 2-naftol substituido | |
| FR2878852B1 (fr) | Procede de production d'immunoglobulines anti-thymocytes humains | |
| TW200514775A (en) | Methods for the preparation of {2-[(8,9)-dioxo-2,6-diaza-bicyclo[5.2.0]-non-1(7)-en-2-yl]ethyl} phosphonic acid and esters thereof | |
| ATE207466T1 (de) | Verfahren zur herstellung von 10,11-dihydro-5h- dibenzo(a,d)cyclohept-5-enen und ihren derivaten | |
| DE3872648D1 (de) | Alkanoylesterverbindungen, zwischenverbindungen dazu und verfahren zur herstellung. | |
| ID22910A (id) | Metode untuk memproduksi fibrinogen |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |